Trademark: 86879881
Word
GLOBOVAX
Status
Dead
Status Code
602
Status Date
Tuesday, June 12, 2018
Serial Number
86879881
Mark Type
4000
Filing Date
Tuesday, January 19, 2016
Published for Opposition
Tuesday, September 6, 2016
Abandoned Date
Tuesday, May 15, 2018

Trademark Owner History
OBI PHARMA, INC. - Owner At Publication

Classifications
5 adjuvants for medical purposes; amino acids for medical purposes; amino acids for veterinary purposes; soap-bark tree, quillaja, quillais and Quillaja saponaria Molina barks for pharmaceutical purposes; biological preparations for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; biological preparations for veterinary purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; chemical reagents for medical or veterinary purposes; chemical preparations for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemical preparations for veterinary purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemico-pharmaceutical preparations for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; drugs for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; glucose for medical purposes; milk sugar for pharmaceutical purposes; lactose for pharmaceutical purposes; medicinal roots; medicinal herbs; medicinal oils; medicinal infusions for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; medicines for human purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; medicines for veterinary purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; pharmaceutical preparations for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; phosphates for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; potassium salts for medical purposes; reagent paper for medical or veterinary purposes; mineral salts for medical purposes; sodium salts for medical purposes; sugar for medical purposes; vaccines; veterinary preparations for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; yeast for pharmaceutical purposes; acetates for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; acids for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; alginates for pharmaceutical purposes; blood for medical purposes; blood plasma; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diastase for medical purposes; enzyme preparations for medical purposes; enzymes for medical purposes; ferments for pharmaceutical purposes; medicated pastilles for pharmaceutical purposes; medicated lozenges for pharmaceutical purposes; flour for pharmaceutical purposes; meal for pharmaceutical purposes; hormones for medical purposes; milk ferments for pharmaceutical purposes; cultures of microorganisms for medical and veterinary use; preparations of microorganisms for medical and veterinary use, namely, nutritive substances for microorganisms for medical and veterinary use; serotherapeutic medicines for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; medicated serums for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; stem cells for medical purposes; anti-cancer preparations; adjuvants for use with vaccines; biological preparations for the treatment of cancer. drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; ferments for medical or veterinary use; human vaccine preparations; medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; reagents for medical use; vaccine adjuvants; vaccine preparations; vaccine stabilizers
GLOBALL VAX

Trademark Events
Jun 12, 2018
Abandonment Notice Mailed - Failure To Respond
Jun 12, 2018
Abandonment - Failure To Respond Or Late Response
Feb 20, 2018
Assigned To Examiner
Nov 14, 2017
Notification Of Non-Final Action E-Mailed
Nov 14, 2017
Non-Final Action E-Mailed
Nov 14, 2017
Non-Final Action Written
Nov 14, 2017
Case Returned To Examination
Oct 27, 2017
Notice Of Allowance Cancelled
Nov 14, 2017
Previous Allowance Count Withdrawn
Nov 2, 2017
Attorney Review/Decision On Amendment Required
Nov 2, 2017
Petition To Director - Change Basis - Granted
Oct 31, 2017
Assigned To Petition Staff
Oct 31, 2017
Notice Of Approval Of Extension Request E-Mailed
Oct 27, 2017
Extension 2 Granted
Oct 27, 2017
Extension 2 Filed
Oct 27, 2017
Teas Extension Received
Oct 9, 2017
Teas Petition To Amend Basis Received
Mar 14, 2017
Notice Of Approval Of Extension Request E-Mailed
Mar 10, 2017
Extension 1 Granted
Mar 10, 2017
Extension 1 Filed
Mar 10, 2017
Teas Extension Received
Nov 1, 2016
Noa E-Mailed - Sou Required From Applicant
Sep 6, 2016
Official Gazette Publication Confirmation E-Mailed
Sep 6, 2016
Published For Opposition
Aug 17, 2016
Notification Of Notice Of Publication E-Mailed
Aug 3, 2016
Law Office Publication Review Completed
Aug 2, 2016
Assigned To Lie
Jul 21, 2016
Approved For Pub - Principal Register
Jul 15, 2016
Teas/Email Correspondence Entered
Jul 14, 2016
Correspondence Received In Law Office
Jul 14, 2016
Teas Response To Office Action Received
Feb 8, 2016
Notification Of Non-Final Action E-Mailed
Feb 8, 2016
Non-Final Action E-Mailed
Feb 8, 2016
Non-Final Action Written
Feb 8, 2016
Assigned To Examiner
Jan 26, 2016
Notice Of Pseudo Mark E-Mailed
Jan 25, 2016
New Application Office Supplied Data Entered In Tram
Jan 22, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24